Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

FACT-Taxane Questionnaire

Known as: FACT-Tax Questionnaire, FACT-Taxane, Functional Assessment of Cancer Therapy-Taxane 
A subscale complement to the FACT-G developed specifically for evaluating the potential side effects of taxane therapy on cancer patients.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
The prognosis of advanced hepatocellular carcinoma (HCC) patients remains extremely poor, partially due to the development of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
SummaryAnthracycline-Taxane chemotherapy is widely used in neoadjuvant treatment for breast cancers. However, there is limited… Expand
Is this relevant?
2011
2011
Background: Docetaxel and paclitaxel are among the most active substances for the treatment of breast cancer. As both drugs are… Expand
  • table 1
  • table 3
  • figure 3
  • figure 2
Is this relevant?
2007
2007
PURPOSE We conducted a multicenter phase II trial to determine the efficacy/safety of capecitabine and weekly paclitaxel, a… Expand
Is this relevant?
Review
2006
Review
2006
High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast cancer: a therapy whose time… Expand
Is this relevant?
2005
2005
BACKGROUND The purpose of this study was to evaluate the tolerability and efficacy of BMS-184476, an analog of paclitaxel, in… Expand
  • table 1
  • table 3
  • table 4
  • table 2
  • figure 1
Is this relevant?
2005
2005
PURPOSE Preclinical studies show that BMS-188797 has a broad spectrum of antitumor activity in in vitro cytotoxicity assays and… Expand
  • figure 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2005
2005
TO THEEDITOR:WecommendKelleretalfortheirstudy evaluating pegylated liposomal doxorubicin (PLD) versus… Expand
Is this relevant?
2004
2004
BackgroundCT-2103 (Cell Therapeutics, Seattle, Wash.) is a water-soluble macromolecular conjugate of paclitaxel to a… Expand
  • table 1
  • table 2
  • figure 1
Is this relevant?